OBJECTIVES Brugada syndrome is a life-threatening disease with an arrhythmogenic
substrate located in the epicardium of right ventricle outflow tract. Therefore, the correct …

Background Brugada syndrome (BrS) is a disease associated with ventricular arrhythmias
and sudden cardiac death. Epicardial ablation has demonstrated high therapeutic efficacy in …

Background Abnormal delayed electrograms (EGMs) from the anterior wall of the right
ventricular outflow tract (RVOT) epicardium have become the ablation target in Brugada …

A 38-year-old man with a diagnosis of Brugada syndrome had a recurrence of monomorphic
ventricular tachycardia 6 years after successful epicardial right ventricular outflow tract …

Following the seminal observation that by eliminating pulmonary vein triggers, recurrent
atrial fibrillation could be prevented, 8 the Bordeaux group pioneered ablation of VF triggers …

Background Ablation approaches have been described for the management of symptomatic
ventricular arrhythmias in patients with Brugada syndrome, but this treatment is still …

Since its first description in 1992, 1 Brugada syndrome (BrS) has claimed global attention as
a remarkable cause of sudden cardiac death in young and otherwise healthy adults …

Aims In the past few years, promising results were described in targeting the arrhythmogenic
substrate of the epicardial right ventricular outflow tract (RVOT) region in patients with …

Background: Radiofrequency ablation (RFA) in Brugada syndrome (BrS) has been
performed both endocardially and epicardially. The substrate in BrS is thus unclear …

Brugada syndrome (BrS) is one of the most common inherited channelopathies associated
with an increased risk of sudden cardiac death. Appropriate use of an ICD in high-risk …